Mit Magzter GOLD unbegrenztes Potenzial nutzen
Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur
Versuchen GOLD - Frei
Zydus sees vaccines, medical devices as new growth drivers
Mint New Delhi
|May 22, 2025
Zydus expects to outperform the Indian pharma market in FY26, while projecting single-digit growth in the US
Zydus Lifesciences Ltd is looking to ramp up its vaccines and medtech portfolio over the next few years, the company's top executive told investors during an earnings call Tuesday evening.
The drugmaker, which announced its Q4FY25 results the same day, expects double-digit revenue growth in FY26, led by strong performance in both domestic and international markets, as well as newer businesses such as biologics, vaccines, and medtech.
"...led by strong growths in India and international markets and also our new growth themes like biologics, vaccines and all scaling up," said managing director Sharvil Patel.
The company expects to outperform the Indian pharmaceutical market in FY26, while projecting single-digit growth in the US.
Diese Geschichte stammt aus der May 22, 2025-Ausgabe von Mint New Delhi.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint New Delhi
Mint New Delhi
Softbank’s 40% fall from peak shows worry on OpenAI bet
Growing unease over frothy artificial intelligence (AI) valuations is weighing on shares of SoftBank Group Corp.
2 mins
November 27, 2025
Mint New Delhi
PepsiCo taps gourmet taste buds with Red Rock Deli’s India debut
Snack and cola maker PepsiCo is finally giving gourmet a chance with the launch of Red Rock Deli chips, priced ₹60 and ₹125 a pack, in a shift from its years-long focus on mass-market Lay's that starts as low as ₹5.
2 mins
November 27, 2025
Mint New Delhi
Fintechs turn fund magnets with cross-border licensing
Funders see growth prospects in central bank's payment aggregator-cross border licensing
3 mins
November 27, 2025
Mint New Delhi
'First-gen founders take bigger investment risks'
India’s markets are minting a new class of first-generation millionaires: entrepreneurs who’ve scaled ideas into Initial public offerings (IPOs) and unlocked unprecedented personal wealth.
2 mins
November 27, 2025
Mint New Delhi
Fundamentum readies four portfolio startups for IPOs
Nandan Nilekani-led venture capital firm Fundamentum is lining up at least four companies in its portfolio for a public listing over the next 12-24 months, co-founder and partner Ashish Kumar said.
2 mins
November 27, 2025
Mint New Delhi
Ukrainians resist pressure from Russia—and Trump
Battered by nearly 4 years of war, Ukrainians don’t want to make big concessions to Moscow
4 mins
November 27, 2025
Mint New Delhi
These firms will sell shovels during semaglutide gold rush
Weight-loss drug semaglutide, also used to treat type-2 diabetes, will face its next big turning point in early 2026, when patents held by Novo Nordisk expire in India.
2 mins
November 27, 2025
Mint New Delhi
IL&FS group repays ₹48,463 cr loan
Debt-ridden IL&FS group has repaid ₹48,463 crore to its creditors as of September 2025, out of the total ₹61,000 crore debt resolution target, as per the latest status report filed before insolvency appellate tribunal NCLAT.
1 min
November 27, 2025
Mint New Delhi
From playlists to pay-lists— streaming platforms go flexi
Audio streaming platforms reshape their business models to turn free listeners into paying subscribers, tiered pricing and micro-transactions have become key to their survival in a market where users are reluctant to pay for content.
2 mins
November 27, 2025
Mint New Delhi
AI trade splinters as Google challenges Nvidia’s dominance
Investors are sending two leaders of the AI trade in opposite directions.
3 mins
November 27, 2025
Listen
Translate
Change font size